Response to correspondence 'Reasons against routine determination of plasma trough levels in PWH treated with intramuscular long acting cabotegravir and rilpivirine as of today'.
| Autor: | van Welzen BJ; Department of Infectious Diseases. University Medical Center Utrecht, Utrecht, The Netherlands., Burger D; Department of Pharmacy, Radboud UMC Institute of Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Wensing AMJ; Translational Virology, Department of Medical Microbiology. University Medical Center Utrecht, Utrecht, The Netherlands.; Ezintsha, Department of Health, University of Witwatersrand. Johannesburg, South Africa. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Mar 14. Date of Electronic Publication: 2024 Mar 14. |
| DOI: | 10.1093/cid/ciae142 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|